The Midwest Center of Excellence for Vector-Borne Disease is leading efforts in the Midwest to better understand and prevent the spread of diseases carried by mosquitos and ticks.
The Midwest Center of Excellence for Vector-Borne Disease (MCEVBD) covers six states: Illinois, Indiana, Iowa, Michigan, Minnesota, and Wisconsin.
Our collaborators are a diverse group of researchers and public health experts located at universities, public health departments, vector control organizations, and private companies throughout the Midwest.
Our Center has three main goals:
#2: Increase opportunities for training in public health entomology
We provide robust training in public health entomology (PHE) to students and young professionals across the Midwest.
We offer two main training programs:
- Research Fellowship
- Public Health Entomology Certificate
Each training program helps trainees become well-prepared to work in vector-borne disease surveillance management roles at academic institutes, public health agencies, and mosquito abatement districts.
#3: Foster community and collaboration among public health and vector control experts across the Midwest
We aim to continue and expand already strong linkages between organizations working in the field of vector-borne disease prevention to better detect and respond to vector-borne disease threats.
The Midwest Center of Excellence for Vector-Borne Disease is headquartered at the University of Wisconsin-Madison, with academic partners at Michigan State University, Loyola University, University of Illinois- Urbana Champaign, Purdue University, University of Notre-Dame, and Indiana University.
Other MCEVBD partners are located at vector control organizations, public health departments, and other academic institutions throughout the Midwest:
The Midwest Center of Excellence for Vector-Borne Disease is supported by Cooperative Agreement Number U01CK000651 from the Centers for Disease Control and Prevention.
MCEVBD was originally established in 2017. In summer 2022, MCE-VBD was renewed for an additional $10M in funding, enabling our work to continue through 2027.